Skip to main content
National Patient Survey 2024 logo.Our National Patient Survey 2024 report is now live. Thank you to all those that shared their experiences. Read our report here.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Muenke Syndrome (MNKES) approved 602849
Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) (due to publishing limitations, we can't provide a link to the relevant minutes - please contact HFEA.Licensing@HFEA.gov.uk if you would like to be sent a copy) approved 231680
Multiple Congenital Anomalies Hypotonia – Seizures Syndrome 1 (MCAHS1) approved 614080
Multiple Congenital Anomalies Hypotonia – Seizures Syndrome 2 (MCAHS2) approved 300868
Multiple Congenital Anomalies Hypotonia – Seizures Syndrome 3 (MCAHS3) approved 615398
Multiple Endocrine Neoplasia Type I (MEN1) approved 131100
Multiple Endocrine Neoplasia, Type IIA (MEN2A) approved 171400
Multiple Endocrine Neoplasia, Type IIB (MEN2B) approved 162300
Multiple Joint Dislocations, Short Stature and Craniofacial Dysmorphism with or without Congenital Heart Defects (JDSCD) approved 245600
Multiple Pterygium Syndrome, Escobar Variant (EVMPS) approved 265000
Multiple Sulfatase Deficiency (MSD) approved 272200
Muscular Dystrophy, Becker Type (BMD) approved 300376
Muscular Dystrophy, Congenital Merosin-Deficient, 1A (MDC1A) approved 607855
Muscular Dystrophy, Congenital, Davignon-Chauveau Type (MDCDC) approved 617066
Muscular dystrophy, congenital, due to Integrin alpha-7 deficiency approved 613204
Muscular Dystrophy, Congenital, LMNA-related, (MDCL) - for cases where there is proven evidence of mosaicism in the blood or as a result of a second affected child approved 613205
Muscular Dystrophy, Congenital, Megaconial Type (MDCMC) approved 602541
Muscular dystrophy, congenital, with cataracts and intellectual disability approved 617404
Muscular Dystrophy, Duchenne Type (DMD) approved 310200
Muscular dystrophy, Limb-Girdle (LGMD) Type 1B approved 159001